Antifungal Activity of Chitosan Nanocomposites against Candida albicans: A Systematic Review

Q2 Pharmacology, Toxicology and Pharmaceutics

Current Bioactive Compounds Pub Date : 2024-04-16 DOI:10.2174/0115734072297928240404074703

P. Shakib, Shirzad Fallahi, G. Goudarzi, Shahram Ahmadi Somaghian, Sana Amiri, Sirus Nemati Delfan, Kourosh Cheraghipour

引用次数: 0

Abstract

This investigation aims to explore the potential anti-Candida albicans effects of Chitosan nanocomposites. Researchers searched several databases, including Scopus, PubMed, Science Direct, Cochrane, and Ovid, for articles published between 2000 and 2023 using specific keywords. Of the 5,600 studies that were first searched in the databases, after removing duplicates (700 cases) and applying inclusion and exclusion criteria, 43 studies were selected for evaluation after duplicate removal. According to studies, the anti-Candida albicans properties of chitosan nanocomposites are more than routine antifungals such as nystatin; therefore, it can be concluded that Chitosan nanocomposites can be used to deal with Candida albicans.

查看原文本刊更多论文

壳聚糖纳米复合材料对白色念珠菌的抗真菌活性：系统综述

研究人员使用特定关键词检索了 Scopus、PubMed、Science Direct、Cochrane 和 Ovid 等多个数据库中 2000 年至 2023 年间发表的文章。根据研究结果，壳聚糖纳米复合材料的抗白色念珠菌性能超过了常规抗真菌药（如奈替丁），因此可以认为壳聚糖纳米复合材料可用于治疗白色念珠菌。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current Bioactive Compounds Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)

CiteScore

1.90

自引率

0.00%

发文量

112

期刊介绍： The journal aims to provide comprehensive review articles on new bioactive compounds with proven activities in various biological screenings and pharmacological models with a special emphasis on stereoeselective synthesis. The aim is to provide a valuable information source of bioactive compounds synthesized or isolated, which can be used for further development of pharmaceuticals by industry and academia. The journal should prove to be essential reading for pharmacologists, natural product chemists and medicinal chemists who wish to be kept informed and up-to-date with the most important developments on new bioactive compounds of natural or synthetic origin, including their stereoeselective synthesis.